Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 37.69B | 39.26B | 34.87B | 33.56B | 29.16B | 32.42B |
Gross Profit | 7.74B | 8.17B | 6.12B | 5.38B | 4.80B | 5.81B |
EBITDA | 3.18B | 4.00B | 1.53B | 1.05B | 651.00M | 1.42B |
Net Income | 2.11B | 2.74B | 899.00M | 556.00M | 310.00M | 885.00M |
Balance Sheet | ||||||
Total Assets | 31.94B | 33.38B | 32.42B | 31.58B | 28.46B | 29.23B |
Cash, Cash Equivalents and Short-Term Investments | 1.94B | 892.00M | 1.45B | 1.60B | 1.59B | 1.54B |
Total Debt | 539.00M | 514.00M | 572.00M | 589.00M | 608.00M | 738.00M |
Total Liabilities | 11.15B | 11.46B | 11.97B | 12.86B | 9.92B | 10.57B |
Stockholders Equity | 20.69B | 21.81B | 20.35B | 18.63B | 18.46B | 18.58B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.01B | 135.00M | 71.00M | -977.00M | 2.62B |
Operating Cash Flow | 0.00 | 1.12B | 190.00M | 123.00M | -589.00M | 2.85B |
Investing Cash Flow | 0.00 | -249.00M | 13.00M | 238.00M | 986.00M | -2.96B |
Financing Cash Flow | 0.00 | -1.08B | -418.00M | -411.00M | -534.00M | -417.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥24.04B | 8.01 | 1.18% | -14.89% | -28.68% | ||
76 Outperform | ¥23.73B | 8.96 | 3.92% | -1.95% | 37.71% | ||
74 Outperform | ¥20.41B | 7.37 | 4.47% | 12.61% | 204.84% | ||
72 Outperform | ¥24.81B | 8.54 | 3.05% | 2.91% | 9.79% | ||
71 Outperform | ¥23.93B | 7.46 | 2.62% | -4.84% | -16.53% | ||
68 Neutral | £2.95B | 10.28 | 8.40% | 3.21% | 2.87% | -9.95% | |
58 Neutral | ¥17.36B | 28.09 | 5.36% | 23.70% | 714.01% |